BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30424780)

  • 1. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [
    Hagens MHJ; Golla SV; Wijburg MT; Yaqub M; Heijtel D; Steenwijk MD; Schober P; Brevé JJP; Schuit RC; Reekie TA; Kassiou M; van Dam AM; Windhorst AD; Killestein J; Barkhof F; van Berckel BNM; Lammertsma AA
    J Neuroinflammation; 2018 Nov; 15(1):314. PubMed ID: 30424780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
    Van Weehaeghe D; Babu S; De Vocht J; Zürcher NR; Chew S; Tseng CJ; Loggia ML; Koole M; Rezaei A; Schramm G; Van Damme P; Hooker JM; Van Laere K; Atassi N
    J Nucl Med; 2020 Nov; 61(11):1621-1627. PubMed ID: 32169920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of neuroinflammation in the HIV-1 transgenic rat: an [(18)F]-DPA714 PET imaging study.
    Lee DE; Yue X; Ibrahim WG; Lentz MR; Peterson KL; Jagoda EM; Kassiou M; Maric D; Reid WC; Hammoud DA
    J Neuroinflammation; 2015 Sep; 12():171. PubMed ID: 26377670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging of Immune Cell Dynamics During De- and Remyelination in the Cuprizone Model of Multiple Sclerosis by [
    Zinnhardt B; Belloy M; Fricke IB; Orije J; Guglielmetti C; Hermann S; Wagner S; Schäfers M; Van der Linden A; Jacobs AH
    Theranostics; 2019; 9(6):1523-1537. PubMed ID: 31037121
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased microglial activation in patients with Parkinson disease using [
    Lavisse S; Goutal S; Wimberley C; Tonietto M; Bottlaender M; Gervais P; Kuhnast B; Peyronneau MA; Barret O; Lagarde J; Sarazin M; Hantraye P; Thiriez C; Remy P
    Parkinsonism Relat Disord; 2021 Jan; 82():29-36. PubMed ID: 33242662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of
    Wimberley C; Lavisse S; Brulon V; Peyronneau MA; Leroy C; Bodini B; Remy P; Stankoff B; Buvat I; Bottlaender M
    J Nucl Med; 2018 Feb; 59(2):307-314. PubMed ID: 28775204
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation.
    Saba W; Goutal S; Kuhnast B; Dollé F; Auvity S; Fontyn Y; Cayla J; Peyronneau MA; Valette H; Tournier N
    Eur J Neurosci; 2015 Jul; 42(1):1738-45. PubMed ID: 25962575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSPO PET with [
    Unterrainer M; Mahler C; Vomacka L; Lindner S; Havla J; Brendel M; Böning G; Ertl-Wagner B; Kümpfel T; Milenkovic VM; Rupprecht R; Kerschensteiner M; Bartenstein P; Albert NL
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1423-1431. PubMed ID: 29523925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [
    Hu W; Pan D; Wang Y; Bao W; Zuo C; Guan Y; Hua F; Yang M; Zhao J
    Front Neurosci; 2020; 14():810. PubMed ID: 33132817
    [No Abstract]   [Full Text] [Related]  

  • 11. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
    Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
    Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.
    Fan Z; Calsolaro V; Atkinson RA; Femminella GD; Waldman A; Buckley C; Trigg W; Brooks DJ; Hinz R; Edison P
    J Nucl Med; 2016 Nov; 57(11):1753-1759. PubMed ID: 27261523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
    Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
    J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative [
    Niu N; Xing H; Wang X; Ding J; Hao Z; Ren C; Ba J; Zheng L; Fu C; Zhao H; Huo L
    Adipocyte; 2020 Dec; 9(1):542-549. PubMed ID: 32902340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
    Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
    Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of the translocator protein positron emission tomography ligand [
    Feeney C; Scott G; Raffel J; Roberts S; Coello C; Jolly A; Searle G; Goldstone AP; Brooks DJ; Nicholas RS; Trigg W; Gunn RN; Sharp DJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study.
    Bunai T; Terada T; Kono S; Yokokura M; Yoshikawa E; Futatsubashi M; Miyajima H; Ouchi Y
    J Neurol Sci; 2018 Feb; 385():30-33. PubMed ID: 29406909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.
    Guo Q; Colasanti A; Owen DR; Onega M; Kamalakaran A; Bennacef I; Matthews PM; Rabiner EA; Turkheimer FE; Gunn RN
    J Nucl Med; 2013 Nov; 54(11):1915-23. PubMed ID: 24071511
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kobayashi M; Jiang T; Telu S; Zoghbi SS; Gunn RN; Rabiner EA; Owen DR; Guo Q; Pike VW; Innis RB; Fujita M
    J Cereb Blood Flow Metab; 2018 Mar; 38(3):393-403. PubMed ID: 28322082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.